NRSN1
geneOn this page
Also known as p24
Summary
NRSN1 (neurensin 1, HGNC:17881) is a protein-coding gene on chromosome 6p22.3, encoding Neurensin-1 (Q8IZ57). May play an important role in neural organelle transport, and in transduction of nerve signals or in nerve growth.
Predicted to be involved in nervous system development. Predicted to be located in cytoplasmic vesicle and growth cone. Predicted to be active in neuron projection; neuronal cell body; and transport vesicle.
Source: NCBI Gene 140767 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 27 total
- MANE Select transcript:
NM_080723
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17881 |
| Approved symbol | NRSN1 |
| Name | neurensin 1 |
| Location | 6p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | p24 |
| Ensembl gene | ENSG00000152954 |
| Ensembl biotype | protein_coding |
| OMIM | 616630 |
| Entrez | 140767 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 9 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000378475, ENST00000378477, ENST00000378478, ENST00000378491, ENST00000463207, ENST00000468195, ENST00000475830, ENST00000892078, ENST00000892079, ENST00000892080, ENST00000944487, ENST00000944488
RefSeq mRNA: 1 — MANE Select: NM_080723
NM_080723
CCDS: CCDS4549
Canonical transcript exons
ENST00000378491 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001085328 | 24128128 | 24128200 |
| ENSE00001282051 | 24126215 | 24126340 |
| ENSE00001477714 | 24145548 | 24147530 |
| ENSE00003650908 | 24134319 | 24134516 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 96.76.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 6.9235 / max 473.6693, expressed in 162 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66378 | 6.9235 | 162 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| dorsolateral prefrontal cortex | UBERON:0009834 | 96.76 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 96.61 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 96.19 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.07 | gold quality |
| nucleus accumbens | UBERON:0001882 | 95.85 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 95.58 | gold quality |
| right frontal lobe | UBERON:0002810 | 95.52 | gold quality |
| frontal cortex | UBERON:0001870 | 95.48 | gold quality |
| hypothalamus | UBERON:0001898 | 95.30 | gold quality |
| neocortex | UBERON:0001950 | 95.09 | gold quality |
| amygdala | UBERON:0001876 | 94.97 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 94.68 | gold quality |
| putamen | UBERON:0001874 | 94.55 | gold quality |
| caudate nucleus | UBERON:0001873 | 94.33 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 93.84 | gold quality |
| cerebral cortex | UBERON:0000956 | 93.74 | gold quality |
| forebrain | UBERON:0001890 | 93.64 | gold quality |
| temporal lobe | UBERON:0001871 | 93.53 | gold quality |
| pituitary gland | UBERON:0000007 | 93.04 | gold quality |
| postcentral gyrus | UBERON:0002581 | 92.77 | gold quality |
| entorhinal cortex | UBERON:0002728 | 92.22 | gold quality |
| parietal lobe | UBERON:0001872 | 91.94 | gold quality |
| pons | UBERON:0000988 | 91.82 | gold quality |
| brain | UBERON:0000955 | 91.80 | gold quality |
| primary visual cortex | UBERON:0002436 | 91.79 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 91.75 | gold quality |
| adenohypophysis | UBERON:0002196 | 91.70 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 91.54 | gold quality |
| cortical plate | UBERON:0005343 | 91.44 | gold quality |
| occipital lobe | UBERON:0002021 | 90.21 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-5061 | yes | 1363.40 |
| E-MTAB-3929 | yes | 348.13 |
| E-ANND-3 | yes | 4.23 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
101 targeting NRSN1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-6755-5P | 99.95 | 65.59 | 464 |
| HSA-MIR-9718 | 99.94 | 68.91 | 918 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
Literature-anchored findings (GeneRIF, showing 5)
- Cloning, expression and characterization of VMP gene. (PMID:12463420)
- dilysine retrieval signal-containing p24 proteins, p24alpha(2) and p24delta(1), bind with gamma-secretase complexes and collaborate in attenuating gamma-cleavage of beta-amyloid precursor protein (PMID:20807314)
- GAL, GAP43 and NRSN1 single nucleotide polymorphisms and related gene-gene interaction networks might be involved in the altered susceptibility to Hirschsprung disease in the Han Chinese population. (PMID:29654647)
- Neuregulin-1 promotes mitochondrial biogenesis, attenuates mitochondrial dysfunction, and prevents hypoxia/reoxygenation injury in neonatal cardiomyocytes. (PMID:32037595)
- Developmental dyslexia susceptibility genes DNAAF4, DCDC2, and NRSN1 are associated with brain function in fluently reading adolescents and young adults. (PMID:38610086)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nrsn1l | ENSDARG00000056572 |
| danio_rerio | nrsn1 | ENSDARG00000111235 |
| mus_musculus | Nrsn1 | ENSMUSG00000048978 |
| rattus_norvegicus | Nrsn1 | ENSRNOG00000017444 |
Paralogs (1): NRSN2 (ENSG00000125841)
Protein
Protein identifiers
Neurensin-1 — Q8IZ57 (reviewed: Q8IZ57)
Alternative names: Neuro-p24, Vesicular membrane protein of 24 kDa
All UniProt accessions (3): Q8IZ57, Q5VTS0, Q5VTS2
UniProt curated annotations — full annotation on UniProt →
Function. May play an important role in neural organelle transport, and in transduction of nerve signals or in nerve growth. May play a role in neurite extension. May play a role in memory consolidation.
Subcellular location. Membrane. Cell projection. Neuron projection.
Tissue specificity. Expressed in brain. Not detectable in other tissues tested.
Similarity. Belongs to the VMP family.
RefSeq proteins (1): NP_542454* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024883 | Neurensin | Family |
Pfam: PF14927
UniProt features (7 total): transmembrane region 2, sequence variant 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IZ57-F1 | 69.20 | 0.23 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 80 (showing top):
TGGTGCT_MIR29A_MIR29B_MIR29C, DARWICHE_SKIN_TUMOR_PROMOTER_UP, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_UP, DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP, MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP, DAWSON_METHYLATED_IN_LYMPHOMA_TCL1, BRN2_01, AACTTT_UNKNOWN, GOCC_NEURON_PROJECTION, GCM_MAPK10, CREBP1_01, LEE_TARGETS_OF_PTCH1_AND_SUFU_DN, NRSF_01, GOCC_CELL_BODY
GO Biological Process (1): nervous system development (GO:0007399)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (7): membrane (GO:0016020), transport vesicle (GO:0030133), growth cone (GO:0030426), cytoplasmic vesicle (GO:0031410), neuron projection (GO:0043005), neuronal cell body (GO:0043025), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| system development | 1 |
| binding | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
| site of polarized growth | 1 |
| distal axon | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
| plasma membrane bounded cell projection | 1 |
| somatodendritic compartment | 1 |
| cell body | 1 |
Protein interactions and networks
STRING
1490 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NRSN1 | ARHGAP9 | Q9BRR9 | 630 |
| NRSN1 | KIAA0319 | Q5VV43 | 582 |
| NRSN1 | DCDC2 | Q9UHG0 | 576 |
| NRSN1 | CAMK2N1 | Q7Z7J9 | 541 |
| NRSN1 | MAPK13 | O15264 | 488 |
| NRSN1 | SRRM4 | A7MD48 | 469 |
| NRSN1 | KCNH4 | Q9UQ05 | 436 |
| NRSN1 | KAAG1 | Q9UBP8 | 435 |
| NRSN1 | NGEF | Q8N5V2 | 424 |
| NRSN1 | DNAAF4 | Q8WXU2 | 424 |
| NRSN1 | HCRTR1 | O43613 | 421 |
| NRSN1 | MAP6D1 | Q9H9H5 | 400 |
| NRSN1 | C6orf62 | Q9GZU0 | 399 |
| NRSN1 | ACOT13 | Q9NPJ3 | 392 |
| NRSN1 | MRS2 | Q9HD23 | 385 |
IntAct
24 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FATE1 | NRSN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRSN1 | TMEM106C | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRSN1 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRSN1 | RNF24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FCGR1A | NRSN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRSN1 | GPA33 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRSN1 | LYVE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRSN1 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.350 |
| NRSN1 | IGLC7 | psi-mi:“MI:0914”(association) | 0.350 |
| NRSN1 | TMEM106C | psi-mi:“MI:0915”(physical association) | 0.000 |
| NRSN1 | SPACA1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NRSN1 | RNF24 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NRSN1 | FCGR1A | psi-mi:“MI:0915”(physical association) | 0.000 |
| NRSN1 | GPA33 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NRSN1 | LYVE1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (177): NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), NRSN1 (Two-hybrid), EGFL7 (Affinity Capture-MS), RHBDD1 (Affinity Capture-MS), MET (Affinity Capture-MS), B4GALT6 (Affinity Capture-MS), B4GALT5 (Affinity Capture-MS), PTPN23 (Affinity Capture-MS), LGR4 (Affinity Capture-MS), FUT8 (Affinity Capture-MS)
ESM2 similar proteins: A6NCQ9, D2H6Z0, D2H788, D3ZBM4, D4A723, E1C2W7, P97432, P97799, Q13145, Q14596, Q3SWY0, Q3T0Y9, Q3TXX3, Q501R9, Q5F479, Q5R7K2, Q5RC94, Q5RF77, Q5T4F4, Q60943, Q60953, Q68D51, Q68EV7, Q6GND7, Q6INB3, Q6P7B7, Q6P9P8, Q80ZD7, Q80ZD8, Q810L3, Q86WK6, Q8BG47, Q8BGE4, Q8C432, Q8CEF8, Q8HYZ0, Q8IZ57, Q8JZL1, Q8N6D2, Q8N8N0
Diamond homologs: P97799, Q5HZK2, Q8IZ57, Q9GZP1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
27 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
761 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:24126297:C:G | donor_gain | 1.0000 |
| 6:24126337:GGGG:G | donor_gain | 1.0000 |
| 6:24126338:GGGG:G | donor_gain | 1.0000 |
| 6:24128196:CAAAG:C | donor_loss | 1.0000 |
| 6:24128197:AAAGG:A | donor_loss | 1.0000 |
| 6:24128198:AAGGT:A | donor_loss | 1.0000 |
| 6:24128199:AGGTA:A | donor_loss | 1.0000 |
| 6:24128200:GGT:G | donor_loss | 1.0000 |
| 6:24128202:T:G | donor_loss | 1.0000 |
| 6:24129408:G:GT | donor_gain | 1.0000 |
| 6:24129412:TTTCA:T | donor_gain | 1.0000 |
| 6:24126338:GGG:G | donor_gain | 0.9900 |
| 6:24126339:GG:G | donor_gain | 0.9900 |
| 6:24126339:GGG:G | donor_gain | 0.9900 |
| 6:24126340:GG:G | donor_gain | 0.9900 |
| 6:24126341:G:A | donor_loss | 0.9900 |
| 6:24126342:TAG:T | donor_loss | 0.9900 |
| 6:24128123:AATAG:A | acceptor_loss | 0.9900 |
| 6:24128125:TAGG:T | acceptor_loss | 0.9900 |
| 6:24128126:A:AG | acceptor_gain | 0.9900 |
| 6:24128126:AG:A | acceptor_gain | 0.9900 |
| 6:24128127:G:GG | acceptor_gain | 0.9900 |
| 6:24128127:GG:G | acceptor_gain | 0.9900 |
| 6:24127096:A:T | donor_gain | 0.9800 |
| 6:24128127:GGATT:G | acceptor_gain | 0.9800 |
| 6:24128201:G:GG | donor_gain | 0.9800 |
| 6:24129419:G:GG | donor_gain | 0.9800 |
| 6:24134317:AGCTG:A | acceptor_gain | 0.9800 |
| 6:24134318:GCT:G | acceptor_gain | 0.9800 |
| 6:24134318:GCTGG:G | acceptor_gain | 0.9800 |
AlphaMissense
1263 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:24134424:T:C | F33L | 0.994 |
| 6:24134426:T:A | F33L | 0.994 |
| 6:24134426:T:G | F33L | 0.994 |
| 6:24134425:T:C | F33S | 0.980 |
| 6:24134425:T:G | F33C | 0.977 |
| 6:24145728:T:C | C124R | 0.975 |
| 6:24145735:G:A | G126E | 0.974 |
| 6:24145584:G:A | G76R | 0.972 |
| 6:24145584:G:C | G76R | 0.972 |
| 6:24145585:G:A | G76E | 0.967 |
| 6:24145563:G:C | G69R | 0.965 |
| 6:24145714:G:A | G119E | 0.965 |
| 6:24145564:G:A | G69D | 0.962 |
| 6:24145737:G:C | G127R | 0.960 |
| 6:24145713:G:A | G119R | 0.957 |
| 6:24145713:G:C | G119R | 0.957 |
| 6:24145734:G:A | G126R | 0.955 |
| 6:24145734:G:C | G126R | 0.955 |
| 6:24145738:G:A | G127D | 0.954 |
| 6:24145755:T:C | C133R | 0.953 |
| 6:24145685:C:A | N109K | 0.942 |
| 6:24145685:C:G | N109K | 0.942 |
| 6:24134404:T:A | V26D | 0.941 |
| 6:24134401:G:A | G25E | 0.935 |
| 6:24145605:G:C | G83R | 0.935 |
| 6:24145606:G:A | G83D | 0.930 |
| 6:24134407:G:C | R27P | 0.927 |
| 6:24134416:T:C | L30P | 0.924 |
| 6:24134404:T:C | V26A | 0.920 |
| 6:24145716:G:C | A120P | 0.920 |
dbSNP variants (sampled 300 via entrez): RS1000028123 (6:24137632 T>G), RS1000427877 (6:24124994 G>T), RS1000437205 (6:24135212 G>A), RS1000808923 (6:24128351 GT>G), RS1000846917 (6:24130599 C>A), RS1000973328 (6:24139524 G>A,C), RS1001048561 (6:24136563 C>T), RS1001415934 (6:24129929 G>C,T), RS1001502977 (6:24140450 T>C), RS1001614340 (6:24145982 T>A,C), RS1001640456 (6:24142476 G>A,T), RS1001817627 (6:24128522 C>G,T), RS1001923509 (6:24141453 T>TC), RS1002063541 (6:24146260 G>A,T), RS1002069858 (6:24146729 A>T)
Disease associations
OMIM: gene MIM:616630 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000905_3 | Information processing speed | 4.000000e-06 |
| GCST002127_32 | Periodontitis (Mean PAL) | 4.000000e-06 |
| GCST004750_77 | Squamous cell lung carcinoma | 3.000000e-06 |
| GCST005023_34 | Initial pursuit acceleration | 5.000000e-08 |
| GCST008114_27 | Type 2 diabetes | 2.000000e-06 |
| GCST008438_3 | Alzheimer’s disease in hypertension | 1.000000e-06 |
| GCST010479_73 | Coronary artery disease | 5.000000e-09 |
| GCST90013406_201 | Liver enzyme levels (alkaline phosphatase) | 2.000000e-46 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004363 | information processing speed |
| EFO:0008434 | initial pursuit acceleration |
| EFO:0004533 | alkaline phosphatase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| jinfukang | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Arsenicals | increases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Triclosan | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): periodontitis, squamous cell lung carcinoma